Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Reproductive mode and fine-scale population genetic structure of grape phylloxera (Daktulosphaira vitifoliae) in a viticultural area in California.

Islam MS, Roush TL, Walker MA, Granett J, Lin H.

BMC Genet. 2013 Dec 24;14:123. doi: 10.1186/1471-2156-14-123.

2.

Consequences of insect herbivory on grape fine root systems with different growth rates.

Bauerle TL, Eissenstat DM, Granett J, Gardner DM, Smart DR.

Plant Cell Environ. 2007 Jul;30(7):786-95.

3.

Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial.

Best PJ, Berger PB, Davis BR, Grines CL, Sadeghi HM, Williams BA, Willerson JT, Granett JR, Holmes DR Jr; PRESTO Investigators.

J Am Coll Cardiol. 2004 Nov 2;44(9):1786-91.

4.

Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease.

Topol EJ, Easton D, Harrington RA, Amarenco P, Califf RM, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Granett J, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Sigmon K, Pieper K, Vallee M, Willerson JT; Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion Trial Investigators.

Circulation. 2003 Jul 29;108(4):399-406. Epub 2003 Jul 21.

PMID:
12874182
5.

Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial.

Holmes DR Jr, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, Fischman D, Goldberg S, Brinker JA, Zeiher AM, Shapiro LM, Willerson J, Davis BR, Ferguson JJ, Popma J, King SB 3rd, Lincoff AM, Tcheng JE, Chan R, Granett JR, Poland M.

Circulation. 2002 Sep 3;106(10):1243-50.

PMID:
12208800
7.

A population pharmacokinetic-pharmacodynamic and logistic regression analysis of lotrafiban in patients.

Mould D, Chapelsky M, Aluri J, Swagzdis J, Samuels R, Granett J.

Clin Pharmacol Ther. 2001 Apr;69(4):210-22.

PMID:
11309549
8.
9.

Biology and management of grape phylloxera.

Granett J, Walker MA, Kocsis L, Omer AD.

Annu Rev Entomol. 2001;46:387-412. Review.

PMID:
11112174
10.

Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease.

Harrington RA, Armstrong PW, Graffagnino C, Van De Werf F, Kereiakes DJ, Sigmon KN, Card T, Joseph DM, Samuels R, Granett J, Chan R, Califf RM, Topol EJ.

Circulation. 2000 Aug 15;102(7):728-35.

PMID:
10942739
11.

Jasmonic acid induced resistance in grapevines to a root and leaf feeder.

Omer AD, Thaler JS, Granett J, Karban R.

J Econ Entomol. 2000 Jun;93(3):840-5.

PMID:
10902339
12.

Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.

Topol EJ, Easton JD, Amarenco P, Califf R, Harrington R, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Willerson JT, Chan R, Samuels R, Ilson B, Granett J.

Am Heart J. 2000 Jun;139(6):927-33.

PMID:
10827369
13.

The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial.

Holmes D, Fitzgerald P, Goldberg S, LaBlanche Jm, Lincoff AM, Savage M, Serruys PW, Willerson J, Granett JR, Chan R, Shusterman NH, Poland M.

Am Heart J. 2000 Jan;139(1 Pt 1):23-31.

PMID:
10618558
15.

Reduced movement of precocious male Atlantic salmon parr into sublethal Dimilin-G1 and carrier concentrations.

Granett J, Morrang S, Hatch R.

Bull Environ Contam Toxicol. 1978 Apr;19(4):462-4. No abstract available.

PMID:
350320
16.

Myocardial infarction associated with coronary angiography.

Granett JR, Mandel GB, Solomon N, Bobroff LM, Scheuer J.

Chest. 1974 Jun;65(6):680-2. No abstract available.

PMID:
4832272

Supplemental Content

Loading ...
Support Center